Luke M. Beshar

Insider Reports History

Entity
Individual
Location
550 Hills Drive, 3 Rd Floor, Bedminster, NJ
Signature
/s/ Mary Grendell, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Luke M. Beshar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 18.1K Jun 7, 2023 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 10K Jun 7, 2024 Direct
REGENXBIO Inc. Director Stock Option (Right to Buy) 10K Jun 4, 2021 Direct
Trillium Therapeutics Inc. Director Deferred Share Unit 0 Nov 17, 2021 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Luke M. Beshar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
OMGA Omega Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
TARA Protara Therapeutics, Inc. Jun 30, 2022 1 $31K 4 Jul 5, 2022 Director
OMGA Omega Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
TARA Protara Therapeutics, Inc. Mar 14, 2022 1 $42.5K 4 Mar 16, 2022 Director
TARA Protara Therapeutics, Inc. Mar 10, 2022 1 $44.6K 4 Mar 14, 2022 Director
TRIL Trillium Therapeutics Inc. Nov 17, 2021 3 $0 4 Nov 19, 2021 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 1 $0 4 Jul 30, 2021 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director
RGNX REGENXBIO Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director